NASDAQ:BIIB
Biogen Idec Inc.
(NASDAQ:BIIB)
269.07
-4.61
(-1.68%)
After-mkt:
269.07
-4.61 (-1.68%)
| 52 Week Rng | - |
| Market Cap | - |
| Avg Volume | - |
| 1M Volatility | - |
| Short Ratio | - |
| P/E Ratio (TTM) | - |
| P/E Ratio (Fwd) | - |
| P/B Ratio | - |
| Div & Yield | - |
ACTION
TICKER
SHARES
STATUS
InvestmentTeam2 • Stockfuse Continuum (US) • 2w
Closing all the open orders from the investment game.
ACTION
TICKER
SHARES
STATUS
ACTION
TICKER
SHARES
STATUS
InvestmentTeam2 • BU52043 Investment Game 2020/21 • Feb 2021
A best value stock. Company focuses on discovery, development and commercialization of pharmaceutical treatments with a strong focus on neurology, oncology and immunology. Has a PE ratio of 9.1
ACTION
TICKER
SHARES
STATUS
ACTION
TICKER
SHARES
STATUS
MinorCrew • Aalto Investment Management Game (Fall 2020) • Dec 2020
Closing position
ACTION
TICKER
SHARES
STATUS
ACTION
TICKER
SHARES
STATUS
Group13 • Aalto Investment Management Game (Fall 2020) • Nov 2020
We sell it because it doesn’t fit our strategy.
ACTION
TICKER
SHARES
STATUS
MorrisMarketNeutral • Stockfuse Continuum (US) • Nov 2020
Closing position
ACTION
TICKER
SHARES
STATUS